Plant Protease Inhibitors: a Defense Strategy in Plants

Total Page:16

File Type:pdf, Size:1020Kb

Plant Protease Inhibitors: a Defense Strategy in Plants Biotechnology and Molecular Biology Review Vol. 2 (3), pp. 068-085, August 2007 Available online at http://www.academicjournals.org/BMBR ISSN 1538-2273 © 2007 Academic Journals Standard Review Plant protease inhibitors: a defense strategy in plants Huma Habib and Khalid Majid Fazili* Department of Biotechnology, The University of Kashmir, P/O Naseembagh, Hazratbal, Srinagar -190006, Jammu and Kashmir, India. Accepted 7 July, 2007 Proteases, though essentially indispensable to the maintenance and survival of their host organisms, can be potentially damaging when overexpressed or present in higher concentrations, and their activities need to be correctly regulated. An important means of regulation involves modulation of their activities through interaction with substances, mostly proteins, called protease inhibitors. Some insects and many of the phytopathogenic microorganisms secrete extracellular enzymes and, in particular, enzymes causing proteolytic digestion of proteins, which play important roles in pathogenesis. Plants, however, have also developed mechanisms to fight these pathogenic organisms. One important line of defense that plants have to fight these pathogens is through various inhibitors that act against these proteolytic enzymes. These inhibitors are thus active in endogenous as well as exogenous defense systems. Protease inhibitors active against different mechanistic classes of proteases have been classified into different families on the basis of significant sequence similarities and structural relationships. Specific protease inhibitors are currently being overexpressed in certain transgenic plants to protect them against invaders. The current knowledge about plant protease inhibitors, their structure and their role in plant defense is briefly reviewed. Key words: Proteases, enzymes, protease inhibitors, serpins, cystatins, pathogens, defense. Table of content 1. Introduction 2. Families of PPIs 2.1 Serpin (Serine PI) family 2.2 Bowman Birk inhibitors (BBIs) family 2.3 Kunitz family 2.4 Squash inhibitors 2.5 Cereal trypsin/-amylase inhibitors 2.6 Mustard (Sinapis) trypsin inhibitor (MSI) 2.7 Potato type I PIs (PI 1) 2.8 Potato type II PIs (PI 2) 2.9 Cysteine PIs (CYS), the cystatin superfamily 2.10 Aspartyl and metallocarboxypeptidase inhibitors 3. Plant protection 4. Transgenic plants 5. Resistance to inhibitors 6. Concluding remarks 7. Acknowledgement 8. References INTRODUCTION Proteolytic enzymes, also called proteases, are the enzy- mes that catalyse the hydrolytic cleavage of specific peptide bonds in their target proteins. These enzymes *Corresponding author. E-mail: [email protected] or are widely distributed in nearly all plants, animals and [email protected]. Phone: 009419003881; +91-194- microorganisms (Joanitti et al., 2006; Neurath, 1989; 2102154; Fax: +91-194-2428723. Valueva and Mosolov, 2004; Christeller, 2005; Haq et al., Abreviations: BBI, Bowman-Birk inhibitor; BTI, Barley trypsin 2004; Supuran et al., 2002; Mosolov and Valueva, 2005; inhibitor; CPI, Cysteine protease inhibitor; CpTi, Cowpea trypsin Mosolov et al., 2001; Lawrence and Koundal, 2002; inhibitor; Cmps, Cucurbita maxima phloem serpin; MSI, Mustard Ryan, 1990). In higher organisms, nearly 2% of the trypsin inhibitor; PI, Protease inhibitor; PPI, Plant PI; PI1, Potato genes code for these enzymes (Barrett et al., 2001). type1PI; PI2, Potato type2 PI; PVy, Potato virus Y; SFTI, Being essentially indispensable to the maintenance and Sunflower trypsin inhibitor; TEV, Tobaco etch virus. Habeeb and Khalid 069 Figure 1A. A diagrammatic model for control of enzyme activity at the level of synthesis. Enzymes may be synthesized as inactive preproteins and are processed to be activated. E represents enzyme, S represents substrate and P represents the products. Figure 1B. Model showing enzymes activity regulation by virtue of substrate specificity. E,S and P have the same meaning as in Figure 1A. survival of their host organism, proteases play key roles their cognate enzymes, and are called protease inhibitors in many biological processes. The proteolytic events (PIs). Trypsin can be considered as a prototype of the catalysed by these enzymes serve as mediators of signal class of enzymes synthesized as inactive precursors. initiation, transmission and termination in many of the Synthesised as trypsinogen, it requires proteolytic pro- cellular events such as inflammation, apoptosis, blood cessing to be activated. Once activated trysin acts clotting and hormone processing pathways (Ivanov et al., specifically only on peptide bonds whose carboxyl func- 2006). Despite the fact that these enzymes are indispen- tions are contributed by lysine or arginine residues. sable to the cells and organisms that host them, they may Further check on the activity of trypsin is due to its be potentially damaging when overexpressed or present interaction with antitrypsin, the protein inhibitor of the in higher concentrations. For this reason the activities of activated form (Laskowski and Qasim, 1999). these enzymes need to be strictly regulated and PIs are of very common occurrence. They have been controlled (Rawlings et al. 2004a). The synthesis of these isolated and characterized from a large number of enzymes as inactive pre-proteins (Figure 1A), and their organisms, including plants, animals and microorganisms substrate specificity (Figure 1B) keeps a control on their (Valueva and Mosolov, 2004; Christeller, 2005; Haq et activities, but it does not fulfill the desired level of al., 2004; Supuran et al., 2002; Mosolov and Valueva, regulation, and the fact remains, that cells and organisms 2005; Mosolov et al., 2001). Naturally occurring PIs are require additional means of control. One important control essential for regulating the activity of their corresponding mechanism involves interaction of the active enzymes proteases and play key regulatory roles in many biolo- with proteins that inhibit their activities (Figure 2). These gical processes. For a few PIs, functions other than inhibitors form less active or fully inactive complexes with blocking protease action have also been found, such as 070 Biotechnol. Mol. Biol. Rev. Families of PIs PIs have been grouped into families and subfamilies and into different clans on the basis of sequence relationship and the relationship of protein folds of the inhibitory domains or units. An inhibitor domain is defined as the segment of the amino acid sequence containing a single reactive site after removal of any parts that are not directly involved in the inhibitor activity. On the basis of sequence homologies of their inhibitor domains, PIs have been classified into 48 families (Rawlings et al., 2004b). Proteins containing a single inhibitor unit are termed simple inhibitors, and those that contain multiple inhibitor units are termed complex inhibitors. A total of 11 families belong to the latter category and contain between 2 and 15 inhibitory domains. Most of these are homotypic, containing inhibitor units from a single family, some are however heterotypic, and contain inhibitor units from different families (Richardson et al., 2001; Trexler et al., Figure 2. Diagrammatic representation of the different modes 2001, 2002). On the basis of tertiary structure, 31 of the of protease inhibition (A) Direct blockage of the active center 48 families have been assigned to 26 clans, indicating canonical inhibition of trysin like proteases (B) Indirect that a large proportion of families show no relationships in blockage of the active center (C) Adjacent or and exocite their three dimensional structures. binding (D) Allosteric interaction. Peptidases have been classified on the basis of structural and evolutionary relationships into different families and clans (Rawlings and Barrett, 1993). These growth factor activities, receptor clearance signaling or families have been divided into five groups based on involvement in carcinogenesis (Qi et al., 2005). A number chemistry of the catalytic site of enzymes (Barrett, 1986, of inherited diseases such as emphysema, and epilepsy 1994; Grudkowska and Zagdanska, 2004). The families result from abnormalities in PIs (Lomas et al., 2002; of PIs could not, however, be grouped on the basis of the Ritchie, 2003; Lehesjoki, 2003; Bitoun et al., 2002) catalytic type of enzymes inhibited, since a number of PIs are of common occurrence in the plant kingdom. families contain cross-class inhibitors (Rawlings et al., Plant PIs (PPIs) are generally small proteins that have 2004b). The proteins in family 13 Kunitz-type PPIs mainly been described as occurring in storage tissues, generally inhibit serine peptidases, but they also include such as tubers and seeds, but they have also been found inhibitors of cysteine and aspartate proteases (Heibges et in the aerial parts of plants (De Leo et al., 2002). They al., 2003). Family 14, the serpin family, mostly contain are also induced in plants in response to injury or attack inhibitors of serine proteases, but it also contains inhibi- by insects or pathogens (Ryan, 1990). In plants, these tors of some cysteine proteases. In the past, however, PIs act as anti-metabolic proteins, which interfere with the PIs have been classified into serine, cysteine, aspartate digestive process of insects. One of the important and metallocarboxy PIs. (De Leo et al., 2002; Laskowski defense strategies that are found in plants to combat et al., 2003; Koiwa et al., 1997). PIs that are active predators involves PIs which are in particular effective against
Recommended publications
  • Downloaded from NCBI
    bioRxiv preprint doi: https://doi.org/10.1101/818179; this version posted October 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Proteolysis and neurogenesis modulated by LNR domain proteins explosion 2 support male differentiation in the crustacean Oithona nana 3 Kevin Sugier1, Romuald Laso-Jadart1, Soheib Kerbache1, Jos Kafer4, Majda Arif1, Laurie Bertrand2, Karine 4 Labadie2, Nathalie Martins2, Celine Orvain2, Emmanuelle Petit2, Julie Poulain1, Patrick Wincker1, Jean-Louis 5 Jamet3, Adriana Alberti2 and Mohammed-Amin Madoui1 6 1. Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Univ Evry, Université 7 Paris-Saclay, Evry, France 8 2. Commissariat à l'Energie Atomique (CEA), Institut François Jacob, Genoscope, Evry, France 9 3. Université de Toulon, Aix-Marseille Université, CNRS/INSU/IRD, Mediterranean Institute of 10 Oceanography MIO UMR 7294, CS 60584, 83041 Toulon cedex 9, France 11 4. Laboratoire de Biométrie et Biologie Evolutive, Université Lyon 1, CNRS UMR 5558, France 12 bioRxiv preprint doi: https://doi.org/10.1101/818179; this version posted October 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 13 Abstract 14 Copepods are the most numerous animals and play an essential role in the marine trophic web 15 and biogeochemical cycles. The genus Oithona is described as having the highest numerical 16 density, as the most cosmopolite copepod and iteroparous. The Oithona male paradox obliges 17 it to alternate feeding (immobile) and mating (mobile) phases.
    [Show full text]
  • The Self-Inhibitory Nature of Metabolic Networks and Its Alleviation Through Compartmentalization
    ARTICLE Received 30 Oct 2016 | Accepted 23 May 2017 | Published 10 Jul 2017 DOI: 10.1038/ncomms16018 OPEN The self-inhibitory nature of metabolic networks and its alleviation through compartmentalization Mohammad Tauqeer Alam1,2, Viridiana Olin-Sandoval1,3, Anna Stincone1,w, Markus A. Keller1,4, Aleksej Zelezniak1,5,6, Ben F. Luisi1 & Markus Ralser1,5 Metabolites can inhibit the enzymes that generate them. To explore the general nature of metabolic self-inhibition, we surveyed enzymological data accrued from a century of experimentation and generated a genome-scale enzyme-inhibition network. Enzyme inhibition is often driven by essential metabolites, affects the majority of biochemical processes, and is executed by a structured network whose topological organization is reflecting chemical similarities that exist between metabolites. Most inhibitory interactions are competitive, emerge in the close neighbourhood of the inhibited enzymes, and result from structural similarities between substrate and inhibitors. Structural constraints also explain one-third of allosteric inhibitors, a finding rationalized by crystallographic analysis of allosterically inhibited L-lactate dehydrogenase. Our findings suggest that the primary cause of metabolic enzyme inhibition is not the evolution of regulatory metabolite–enzyme interactions, but a finite structural diversity prevalent within the metabolome. In eukaryotes, compartmentalization minimizes inevitable enzyme inhibition and alleviates constraints that self-inhibition places on metabolism. 1 Department of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK. 2 Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, UK. 3 Department of Food Science and Technology, Instituto Nacional de Ciencias Me´dicas y Nutricio´n Salvador Zubira´n, Vasco de Quiroga 15, Tlalpan, 14080 Mexico City, Mexico.
    [Show full text]
  • Effect of Statins and ACE Inhibitors Alone and in Combination on Clinical Outcome in Patients with Coronary Heart Disease
    Journal of Human Hypertension (2004) 18, 781–788 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease VG Athyros1, DP Mikhailidis3, AA Papageorgiou2, VI Bouloukos1, AN Pehlivanidis1, AN Symeonidis4 and M Elisaf5, for the GREACE Study Collaborative Group 1Atherosclerosis Unit, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece; 2Department of Clinical Biochemistry, Royal Free Hospital, Royal Free and University College Medical School, Pond Street, London, UK; 32nd Propedeutic Department of Internal Medicine, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece; 4Greek Society of General Practitioners, Thessaloniki, Greece; 5Department of Internal Medicine, Medical School, University of Ioannina, Greece We assessed the ‘synergy’ of statins and angiotensin- point in group A was 31%, (95% CI À48 to À6%, P ¼ 0.01) converting enzyme inhibitors (ACEI) in reducing vascu- in comparison to group B, 59% (95% CI À72 to À48%, lar events in patients with coronary heart disease (CHD). Po0.0001) to group C and 63% (95% CI À74 to À51%, The GREek Atorvastatin and CHD Evaluation (GREACE) Po0.0001) to group D. There was no significant Study, suggested that aggressive reduction of low difference in RRR between groups C and D (9%, CI density lipoprotein cholesterol to 2.59 mmol/l À27–10%, P ¼ 0.1). Other factors (eg the blood pressure) (o100 mg/dl) significantly reduces morbidity and mor- that can influence clinical outcome did not differ tality in CHD patients, in comparison to undertreated significantly between the four treatment groups.
    [Show full text]
  • Functional Characterization of Extracellular Protease Inhibitors of Phytophthora Infestans
    FUNCTIONAL CHARACTERIZATION OF EXTRACELLULAR PROTEASE INHIBITORS OF PHYTOPHTHORA INFESTANS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Miaoying Tian, M.S. * * * * * The Ohio State University 2005 Dissertation Committee: Dr. Sophien Kamoun, Adviser Dr. Terrence L. Graham Approved by Dr. Saskia A. Hogenhout Dr. Margaret G. Redinbaugh Adviser Dr. Guo-Liang Wang Graduate Program in Plant Pathology ABSTRACT The oomycetes form one of several lineages within the eukaryotes that independently evolved a parasitic lifestyle and are thought to have developed unique mechanisms of pathogenicity. The devastating oomycete plant pathogen Phytophthora infestans causes late blight, a ravaging disease of potato and tomato. Little is known about processes associated with P. infestans pathogenesis, particularly the suppression of host defense responses. We used data mining of P. infestans sequence databases to identify 18 extracellular protease inhibitors belonging to two major structural classes: (i) Kazal-like serine protease inhibitors (EPI1 to EPI14) and (ii) cystatin-like cysteine protease inhibitors (EPIC1 to EPIC4). A variety of molecular, biochemical and bioinformatic approaches were employed to functionally characterize these genes and investigate their roles in pathogen virulence. The 14 EPI proteins form a diverse family and appear to have evolved by domain shuffling, gene duplication, and diversifying selection to target a diverse array of serine proteases. Recombinant EPI1 and EPI10 proteins inhibited subtilisin A among major serine proteases, and inhibited and interacted with tomato P69B subtilase, a pathogenesis-related protein belonging to PR7 class. The recombinant cystatin-like cysteine protease inhibitor EPIC2B interacted with a novel tomato papain-like extracellular cysteine protease PIP1 with an implicated role in plant defense.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Evidence for Two Different Modes of Tripeptide Disappearance in Human Intestine. Uptake by Peptide Carrier Systems and Hydrolysis by Peptide Hydrolases
    Evidence for two different modes of tripeptide disappearance in human intestine. Uptake by peptide carrier systems and hydrolysis by peptide hydrolases. S A Adibi, … , S S Masilamani, P M Amin J Clin Invest. 1975;56(6):1355-1363. https://doi.org/10.1172/JCI108215. Research Article The intestinal fate of two tripeptides (triglycine and trileucine), which differ markedly in solubility and molecular weight, have been investigated by jejunal perfusion in healthy human volunteers. Rates of glycine or leucine uptake from test solutions containing triglycine or trileucine were greater than from test solutions containing corresponding amounts of free glycine or free leucine, respectively. The rate of glycine uptake from a 100 mM triglycine solution was greater than that from a 150 mM diglycine solution. At each infused load of triglycine (e.g., 1,000 mumol/min) the rates (micromoles/minutes per 30 cm) of either triglycine disappearance (810 +/- 40) or glycine absorption (2,208 +/- 122) were markedly greater than the luminal accumulation rates of either diglycine (56 +/- 10) or free glycine (110 +/- 18). The luminal accumulation rate of free leucine during infusion of a 5 mM trileucine solution was over threefold greater than that of free glycine during the infusion of a 5 mM triglycine solution. Luminal fluid exhibited no hydrolytic activity against triglycine, but contained some activity against trileucine. Saturation of free amino acid carrier system with a large load of leucine did not affect glycine absorption rate from a triglycine test solution, but isoleucine markedly inhibited the uptake from a trileucine solution. When the carrier system for dipeptides was saturated with a large amount of glycylleucine, […] Find the latest version: https://jci.me/108215/pdf Evidence for Two Different Modes of Tripeptide Disappearance in Human Intestine UPTAKE BY PEPTIDE CARRIER SYSTEMS AND HYDROLYSIS BY PEPTIDE HYDROLASES SIAMAK A.
    [Show full text]
  • Safety Assessment of Tripeptide-1, Hexapeptide-12, and Related Amides As Used in Cosmetics
    Safety Assessment of Tripeptide-1, Hexapeptide-12, and Related Amides as Used in Cosmetics Status: Draft Report for Panel Review Release Date: February 21, 2014 Panel Meeting Date: March 17-18, 2014 The 2014 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A Hill, Ph.D. James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This report was prepared by Wilbur Johnson, Jr., M.S., Senior Scientific Analyst and Bart Heldreth, Ph.D., Chemist. © Cosmetic Ingredient Review 1620 L STREET, N.W., SUITE 1200 ◊ WASHINGTON, DC 20036-4702 ◊ PH 202.331.0651 ◊ FAX 202.331.0088 ◊ [email protected] Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Wilbur Johnson, Jr. Senior Scientific Analyst Date: February 21, 2014 Subject: Draft Report on Tripeptide-1, Hexapeptide-12, and Related Amides The draft report on palmitoyl oligopeptides was tabled at the March 18-19, 2013 CIR Expert Panel meeting, pending reorganization of the safety assessment. During the meeting, the Panel was provided with a letter from the CIR Science and Support Committee, recommending the creation of a new ingredient group consisting of ingredients for which the peptide sequence is known, namely, tripeptide -1, hexapeptide-12 and specific related amides. This has been done. Additionally, at the March meeting, further information was sought to better understand the extent and manner in which solid-phase peptide synthesis is used to create the peptide portion of ingredients included in the safety assessment.
    [Show full text]
  • TRH-Like Peptides
    Physiol. Res. 60: 207-215, 2011 https://doi.org/10.33549/physiolres.932075 REVIEW TRH-Like Peptides R. BÍLEK1, M. BIČÍKOVÁ1, L. ŠAFAŘÍK2 1Institute of Endocrinology, Prague, Czech Republic, 2Urology Clinic, Beroun, Czech Republic Received September 6, 2010 Accepted October 8, 2010 On-line November 29, 2010 Summary of the leaders working in the area concerning the TRH TRH-like peptides are characterized by substitution of basic research was Professor V. Schreiber from Prague, Czech amino acid histidine (related to authentic TRH) with neutral or Republic, which already in 1959 formulated the acidic amino acid, like glutamic acid, phenylalanine, glutamine, hypothesis that adenohypophyseal acid phosphatase is tyrosine, leucin, valin, aspartic acid and asparagine. The related to thyrotropin secretion and that TRH is its presence of extrahypothalamic TRH-like peptides was reported in possible activator (Schreiber and Kmentova 1959, peripheral tissues including gastrointestinal tract, placenta, neural Schreiber et al. 1962). TRH precursor, human prepro- tissues, male reproductive system and certain endocrine tissues. TRH, consists of 242 amino acid residues, and contains Work deals with the biological function of TRH-like peptides in six separate copies of the TRH progenitor sequence different parts of organisms where various mechanisms may (Satoh and Mori 1994), which determine the primary serve for realisation of biological function of TRH-like peptides as structure of TRH as a tripeptide pyroglutamyl-histidinyl- negative feedback to the pituitary exerted by the TRH-like proline amide. The transcriptional unit of prepro-TRH is peptides, the role of pEEPam such as fertilization-promoting localized on chromosome 3 in humans (three exons peptide, the mechanism influencing the proliferative ability of interrupted by two introns) (Yamada et al.
    [Show full text]
  • Ultraviolet Irradiation on a Pyrite Surface Improves Triglycine Adsorption
    life Article Ultraviolet Irradiation on a Pyrite Surface Improves Triglycine Adsorption Santos Galvez-Martinez and Eva Mateo-Marti * Centro de Astrobiología (CSIC-INTA), Ctra. Ajalvir, Km. 4, 28850 Torrejón de Ardoz, Spain; [email protected] * Correspondence: [email protected]; Tel.: + 34-915-872-973 Received: 27 July 2018; Accepted: 9 October 2018; Published: 25 October 2018 Abstract: We characterized the adsorption of triglycine molecules on a pyrite surface under several simulated environmental conditions by X-ray photoemission spectroscopy. The triglycine molecular adsorption on a pyrite surface under vacuum conditions (absence of oxygen) shows the presence of + two different states for the amine functional group (NH2 and NH3 ), therefore two chemical species (anionic and zwitterionic). On the other hand, molecular adsorption from a solution discriminates the NH2 as a unique molecular adsorption form, however, the amount adsorbed in this case is higher than under vacuum conditions. Furthermore, molecular adsorption on the mineral surface is even favored if the pyrite surface has been irradiated before the molecular adsorption occurs. Pyrite surface chemistry is highly sensitive to the chemical changes induced by UV irradiation, as XPS analysis shows the presence of Fe2O3 and Fe2SO4—like environments on the surface. Surface chemical changes induced by UV help to increase the probability of adsorption of molecular species and their subsequent concentration on the pyrite surface. Keywords: pyrite; triglycine; XPS; peptide; sulfide mineral; UV; surface; adsorption; prebiotic chemistry 1. Introduction Minerals can be very promising surfaces for studying biomolecule surface processes, which are of principal relevance in the origin of life and a source of chemical complexity [1,2].
    [Show full text]
  • Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 As Used in Cosmetics
    Safety Assessment of Tripeptide-1, Hexapeptide-12, their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics Status: Draft Final Report for Panel Review Release Date: May 16, 2014 Panel Meeting Date: June 9-10, 2014 The 2014 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A Hill, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This report was prepared by Wilbur Johnson, Jr., M.S., Senior Scientific Analyst and Bart Heldreth, Ph.D., Chemist. © Cosmetic Ingredient Review 1620 L STREET, N.W., SUITE 1200 ◊ WASHINGTON, DC 20036-4702 ◊ PH 202.331.0651 ◊ FAX 202.331.0088 ◊ [email protected] Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Wilbur Johnson, Jr. Senior Scientific Analyst Date: May 16, 2014 Subject: Draft Final Report on Tripeptide-1, Hexapeptide-12, their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 At the March 17-18, 2014 Expert Panel meeting, the Panel concluded that tripeptide-1, hexapeptide-12, their metal salts and fatty acyl derivatives, and palmitoyl tetrapeptide-7 are safe in the present practices of use and concentration and issued a tentative report. Comments and use concentration data received from the Council have been addressed/ incorporated. Included in this package for your review is the draft final report, the CIR report history, Literature search strategy, Ingredient Data profile, 2014 FDA VCRP data, Minutes from the March 2014 Panel Meeting, and comments (pcpc1pdf file) and use concentration data (data 1 file) received from the Council.
    [Show full text]
  • Kinase-Targeted Cancer Therapies: Progress, Challenges and Future Directions Khushwant S
    Bhullar et al. Molecular Cancer (2018) 17:48 https://doi.org/10.1186/s12943-018-0804-2 REVIEW Open Access Kinase-targeted cancer therapies: progress, challenges and future directions Khushwant S. Bhullar1, Naiara Orrego Lagarón2, Eileen M. McGowan3, Indu Parmar4, Amitabh Jha5, Basil P. Hubbard1 and H. P. Vasantha Rupasinghe6,7* Abstract The human genome encodes 538 protein kinases that transfer a γ-phosphate group from ATP to serine, threonine, or tyrosine residues. Many of these kinases are associated with human cancer initiation and progression. The recent development of small-molecule kinase inhibitors for the treatment of diverse types of cancer has proven successful in clinical therapy. Significantly, protein kinases are the second most targeted group of drug targets, after the G-protein- coupled receptors. Since the development of the first protein kinase inhibitor, in the early 1980s, 37 kinase inhibitors have received FDA approval for treatment of malignancies such as breast and lung cancer. Furthermore, about 150 kinase-targeted drugs are in clinical phase trials, and many kinase-specific inhibitors are in the preclinical stage of drug development. Nevertheless, many factors confound the clinical efficacy of these molecules. Specific tumor genetics, tumor microenvironment, drug resistance, and pharmacogenomics determine how useful a compound will be in the treatment of a given cancer. This review provides an overview of kinase-targeted drug discovery and development in relation to oncology and highlights the challenges and future potential for kinase-targeted cancer therapies. Keywords: Kinases, Kinase inhibition, Small-molecule drugs, Cancer, Oncology Background Recent advances in our understanding of the fundamen- Kinases are enzymes that transfer a phosphate group to a tal molecular mechanisms underlying cancer cell signaling protein while phosphatases remove a phosphate group have elucidated a crucial role for kinases in the carcino- from protein.
    [Show full text]
  • Insights Into the Role of Tick Salivary Protease Inhibitors During Ectoparasite–Host Crosstalk
    International Journal of Molecular Sciences Review Insights into the Role of Tick Salivary Protease Inhibitors during Ectoparasite–Host Crosstalk Mohamed Amine Jmel 1,† , Hajer Aounallah 2,3,† , Chaima Bensaoud 1, Imen Mekki 1,4, JindˇrichChmelaˇr 4, Fernanda Faria 3 , Youmna M’ghirbi 2 and Michalis Kotsyfakis 1,* 1 Laboratory of Genomics and Proteomics of Disease Vectors, Biology Centre CAS, Institute of Parasitology, Branišovská 1160/31, 37005 Ceskˇ é Budˇejovice,Czech Republic; [email protected] (M.A.J.); [email protected] (C.B.); [email protected] (I.M.) 2 Institut Pasteur de Tunis, Université de Tunis El Manar, LR19IPTX, Service d’Entomologie Médicale, Tunis 1002, Tunisia; [email protected] (H.A.); [email protected] (Y.M.) 3 Innovation and Development Laboratory, Innovation and Development Center, Instituto Butantan, São Paulo 05503-900, Brazil; [email protected] 4 Faculty of Science, University of South Bohemia in Ceskˇ é Budˇejovice, 37005 Ceskˇ é Budˇejovice, Czech Republic; [email protected] * Correspondence: [email protected] † These authors contributed equally. Abstract: Protease inhibitors (PIs) are ubiquitous regulatory proteins present in all kingdoms. They play crucial tasks in controlling biological processes directed by proteases which, if not tightly regulated, can damage the host organism. PIs can be classified according to their targeted proteases or their mechanism of action. The functions of many PIs have now been characterized and are showing clinical relevance for the treatment of human diseases such as arthritis, hepatitis, cancer, AIDS, and cardiovascular diseases, amongst others. Other PIs have potential use in agriculture as insecticides, anti-fungal, and antibacterial agents.
    [Show full text]